Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 12/20 | 0.63 |
| ▸ | PTGER2 | P43116 | 11/20 | 0.63 |
| ▸ | PTGER4 | P35408 | 9/20 | 0.63 |
| ▸ | PTGDR | Q13258 | 5/20 | 0.59 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | PTGFR | P43088 | 3/20 | 0.56 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.56 |
| ▸ | PTGIR | P43119 | 2/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | TNKS | O95271 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3214322 | 1.00 | PTGER3 (0.63) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL1150939 | 1.00 | PTGER3 (0.63) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| Methacrylic Acid SCHEMBL10714797 | 0.90 | PTGER3 (0.54) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL5007834 | 0.89 | PTGER3 (0.52) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL7134072 | 0.87 | EGFR (0.57) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL28893816 | 0.87 | PTGER3 (0.58) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL3256824 | 0.87 | PTGER3 (0.58) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL7499883 | 0.86 | NFKB1 (0.60) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL5873000 | 0.86 | CA1 (0.53) | PTGER3PTGER2PTGER4PTGDRTBXA2R | |
| SCHEMBL12075162 | 0.85 | LMNA (0.61) | PTGER3PTGER2PTGER4PTGDRTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426105-B1 | COCOA PLANT CELL CULTURE PROCESSING METHODS AND PRODUCTS OBTAINED BY THE SAME | ZHAW ZUERCHER HOCHSCHULE FUER ANGEWANDTE WSS (CH) | 2026-04-29 | — | — | EP | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4609167-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | Centre National de la Recherche Scientifique (FR) | 2025-09-03 | — | — | EP | claimed |
| EP-4525822-A1 | ANTIMICROBIAL MIXTURES | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| EP-4255208-B1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-12-25 | — | — | EP | claimed |
| EP-3930472-B1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-09-11 | — | — | EP | claimed |
| WO-2024089224-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-05-02 | — | — | WO | claimed |
| EP-3548890-B1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2024-03-27 | — | — | EP | claimed |
| EP-4297900-A2 | CONTAINER FOR A SAMPLE AND METHOD FOR EXAMINING A SAMPLE WITH THE CONTAINER | Paul Marienfeld GmbH & Co. KG (DE) | 2024-01-03 | — | — | EP | claimed |
| US-20230383163-A1 | COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE | KD FINECHEM CO., LTD. (KR) | 2023-11-30 | — | — | US | claimed |
| WO-2001066827-A1 | METHOD FOR PROVIDING METAL SURFACES WITH PROTECTION AGAINST CORROSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-09-13 | — | — | WO | claimed |
| EP-0958402-A1 | ZINC PHOSPHATING WITH INTEGRATED SUBSEQUENT PASSIVATION | Henkel Kommanditgesellschaft auf Aktien (DE) | 1999-11-24 | — | — | EP | claimed |
| US-5876492-A | Ink compositions containing esters | XEROX CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-0596493-B1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO LTD (JP) | 1999-02-03 | — | — | EP | claimed |
| EP-0428276-B1 | Acaricidal composition | TAKASAGO PERFUMERY CO LTD (JP) | 1998-09-16 | — | — | EP | claimed |
| WO-1997045568-A1 | ZINC PHOSPHATING WITH INTEGRATED SUBSEQUENT PASSIVATION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-12-04 | — | — | WO | claimed |
| EP-0319016-B1 | Treatment and after-treatment of metal with polyphenol compounds | HENKEL CORP (US) | 1994-06-22 | — | — | EP | claimed |
| EP-0319017-B1 | Treatment and after-treatment of metal with carbohydrate-modified polyphenol compounds | HENKEL CORP (US) | 1994-04-13 | — | — | EP | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| EP-0009041-B1 | PROCESS FOR PREPARING AROMATIC AMIDE ANTIOXIDANTS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1982-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | PTGER3 1464/4885PTGER2 1673/4885PTGER4 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.